Hydrocortisone And Acetic Acid
NDC Package 45963-412-61

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Hydrocortisone And Acetic Acid is a . Marketed by Actavis Pharma, Inc., this product is identified by NDC 45963-412 and is authorized under FDA application ANDA087143.

Identification & Billing

NDC Package Code
45963-412-61
Package Description
1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
45963041261
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Hydrocortisone And Acetic Acid
Dosage Form
-

Regulatory & Marketing

Labeler Name
Actavis Pharma, Inc.
FDA Application #
ANDA087143
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-29-2009
End Marketing Date
03-31-2017
Listing Expiration
03-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45963-412-61 identifies a specific commercial package of 1 bottle in 1 carton / 10 ml in 1 bottle of Hydrocortisone And Acetic Acid, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on June 29, 2009. The current certification is valid through March 31, 2017.

How is this Actavis Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45963041261. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45963-412-61
11-Digit CMS (5-4-2)
45963-0412-61

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.